Amgen Inc. - Company & Market Research Reports

Home /
Companies /
Amgen Inc.

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 334
Immune Disorders Drugs 206
Biopharmaceuticals 175
Musculoskeletal Disorders Drugs 125
Genomics 115
Cardiovascular Drugs 104
Biotechnology 84
Pharmaceuticals 81
Drug Discovery 77
Endocrine and Metabolic Disorders Drugs 76
Biosimilars and Biosuperiors 72
Allergy and Immunology 67
Infusions and Injectables 64
Leukemia Drugs 63
Hematological Drugs 60
Oncology 52
Clinical Trials 51
Dermatological Drugs 51
Central Nervous System Drugs 49
Liver and Kidney Disorders Drugs 45
Women's Health 44
Needles and Syringes 41
Drug Delivery 38
Psoriasis Drugs 37
Diagnostics 36
Skin Cancer Drugs 35
Hematology 30
Infectious Diseases Drugs 28
Brain Cancer Drugs 28
Enzymes 27
Lung Cancer Drugs 26
Colon Cancer Drugs 26
Proteomics 26
Gastrointestinal Drugs 26
Analgesics 24
Immunosuppressive Drugs 24
Lymphoma Drugs 23
Pharmaceutical Manufacturing 19
Drugs by Therapeutic Area 18
Dermatology 18
Optical 17
Therapeutic Area 16
Respiratory Drugs 16
Urology and Nephrology 15
Healthcare Services 14
Kidney Cancer Drugs 14
Optical Disorders Drugs 13
Pancreatic Cancer Drugs 12
Nanomedicine 11
Generic Drugs 10
Breast Cancer Drugs 10
Prostate Cancer Drugs 10
Ovarian Cancer Drugs 10
Cervical Cancer Drugs 10
Cardiology 10
Sexual and Reproductive Health Drugs 10
E-Healthcare 9
Liver Cancer Drugs 8
Cancer Vaccines 8
Other Healthcare Facilities 8
Pulmonary Medicine 7
In Vitro Diagnostics 7
Biomarkers 7
Anti-Obesity Drugs 7
Gastroenterology 7
Neurology 6
Diabetes Drugs 6
Biomaterials 6
Vaccines 6
Mental Disorders Drugs 6
Company Reports 5
Animal Pharmaceuticals 5
Medical Devices 5
Molecular Diagnostics 5
Over the Counter (OTC) Drugs 5
Pediatrics 5
Asthma Drugs 5
Pharmaceutical Intermediates 4
Surgical Procedures 4
Thyroid Cancer Drugs 4
Alzheimer's Disease Drugs 4
Managed Care 3
Stem Cells 3
Endocrinology 3
Addiction Disorders Drugs 2
Bladder Cancer Drugs 2
Cardiovascular Devices 2
Infectious Disease Testing 2
Inhalers and Nebulisers 2
Mental Health 2
Uterine Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Antibiotics 2
Acne Drugs 2
Urological Disorders Drugs 2
Schizophrenia Drugs 2
Hepatology 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Orthopedic Devices 1
Cholesterol Testing 1
Cough and Cold Drugs 1
Healthcare 1
Radiography 1
Transdermal and Transmucosal Drug Delivery 1
Blood Banking 1
Hospital Management 1
Respiratory Devices 1
Clinical Therapies 1
Clinical Skills 1
Palliative Care 1
Anatomy 1
Maternal and Neonatal Care 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

2,078 Results (Page 31 of 104)
- Relevance
  Sort by

Auto Injector Market - Forecasts from 2024 to 2029

 Report
April 2024
134 Pages
Global

From

€3518EUR$3,950USD£3,071GBP

Multiple Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
696 Pages
Global

From

€2227EUR$2,500USD£1,944GBP

Biomedical and ICT Convergence Market by Technology, Solution and Region 2025-2030

 Report
December 2025
167 Pages
Global

From

€3118EUR$3,500USD£2,721GBP

Axial Spondyloarthritis - Market Insight, Epidemiology and Market Forecast - 2034

 Report
July 2024
231 Pages
Global

From

€7081EUR$7,950USD£6,181GBP

Gynecological Cancer Drugs Market - Global Forecast 2026-2032

 Report
January 2026
182 Pages
Global

From

€3158EUR$3,545USD£2,756GBP

€3509EUR$3,939USD£3,063GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

US Acute Myeloid Leukemia Market to 2028

 Report
October 2023
85 Pages
United States

From

€4320EUR$4,850USD£3,771GBP

Psoriatic Arthritis - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7081EUR$7,950USD£6,181GBP

Mammalian Cell Fermentation Technology - Global Strategic Business Report

 Report
May 2026
392 Pages
Global

From

€5211EUR$5,850USD£4,549GBP

Large and Small-scale Bioprocessing - Global Strategic Business Report

 Report
May 2026
565 Pages
Global

From

€5211EUR$5,850USD£4,549GBP

Biomanufacturing Market - Global Strategic Business Report

 Report
May 2026
375 Pages
Global

From

€5211EUR$5,850USD£4,549GBP

Bispecific Antibody Therapeutics Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
June 2025
190 Pages
Global

From

€4008EUR$4,500USD£3,499GBP

Wearable Injectors - Market Insights, Competitive Landscape, and Market Forecast - 2030

 Report
July 2024
100 Pages
Global

From

€3340EUR$3,750USD£2,916GBP

Autoinjectors - Market Insights, Competitive Landscape, and Market Forecast - 2030

 Report
July 2024
150 Pages
Global

From

€3340EUR$3,750USD£2,916GBP

Pneumatic Compression Therapy Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3999EUR$4,490USD£3,491GBP

Biosimilars Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4408EUR$4,949USD£3,848GBP

Predictive Presymptomatic Testing Market 2024-2028

 Report
July 2024
136 Pages
Global

From

€2227EUR$2,500USD£1,944GBP

T-Cell & NK-Cell Engaging Bispecific Antibodies Market - Global Forecast 2025-2030

 Report
August 2025
191 Pages
Global

From

€3158EUR$3,545USD£2,756GBP

€3509EUR$3,939USD£3,063GBP

Humanized Bispecific Antibodies Market - Global Forecast 2025-2030

 Report
August 2025
190 Pages
Global

From

€3158EUR$3,545USD£2,756GBP

€3509EUR$3,939USD£3,063GBP

Gynecological Cancer Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3999EUR$4,490USD£3,491GBP

Current Research & Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy

 Report
December 2021
353 Pages
Global

From

€4899EUR$5,500USD£4,276GBP

2,078 Results (Page 31 of 104)
- 1
- 29
- 30
- 31
- 32
- 33

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.